Boehringer Ingelheim Announces 2023 Advancement in Equine Research Award Recipients

Equine infectious disease and equine asthma syndrome research receive funding.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

DULUTH, GA (December 5, 2023) – Boehringer Ingelheim Animal Health announced the recipients of the 2023 Advancement in Equine Research Awards during the 69th annual American Association of Equine Practitioners Convention in San Diego, CA, November 29 – December 3. The recipients were chosen based on their research proposals which included subject matter focused on equine infectious disease and equine asthma syndrome.

Recipients are the following:

Kate Hepworth, DVM, DACVIM, Katie Sheets, DVM, PhD, DACVIM,

Katarzyna Dembek, DVM, PhD, DACVIM and Nathan Nelson, DVM, MS

North Carolina State University, Raleigh, NC

Kelsey Hart DVM, PhD, DACVIM and Clare A. Ryan, DVM, PhD, DACVIM

University of Georgia, Athens, GA

Brian Gilger, DVM, MS DACVO, DABT and Darby Roberts*, BS

North Carolina State University, Raleigh, NC

Nicola Pusterla, DVM, PhD, DACVIM

University of California, Davis, CA

*Resident/PhD student proposal

With the inclusion of this year’s recipients, Boehringer Ingelheim has given more than $800,000 towards the advancement of equine research since 2011.

“At Boehringer Ingelheim, we acknowledge that the health and well-being of animals is pivotal to the success and development of human life. Our dedication and passion for the advancement of equine research makes Boehringer Ingelheim a global leader in its field,” said Steve Grubbs, DVM, PhD, DACVIM, equine technical manager for Boehringer Ingelheim. “Previous award recipients have made novel research advancements in equine infectious diseases and equine asthma syndrome and we anticipate that this year’s recipients will follow suit.” 

Those eligible to submit proposals were veterinarians, diagnosticians, and public and private researchers in the United States, Canada and Mexico.

For more information about the Advancement in Equine Research Awards, click here. 

###

About Boehringer Ingelheim Animal Health USA Inc.

Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers, and governments in more than 150 countries, we offer a large and innovative portfolio of products and services to improve the health and well-being of companion animals and livestock. 

As a global leader in the animal health industry and as part of the family-owned Boehringer Ingelheim, we take a long-term perspective. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Pharma businesses and by delivering value through innovation, we enhance the health and well-being of both.  

Boehringer Ingelheim Animal Health has deep roots in the U.S. From a start in St. Joseph, Missouri, more than 100 years ago, it has grown to encompass seven sites. Boehringer Ingelheim Animal Health’s portfolio contains widely used and well-respected vaccines, parasite-control products and therapeutics for pets, horses and livestock.

©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved.

US-EQU-0357-2023

For more information:

Colleen Scott

Public Relations Supervisor

Broadhead + Co.

(816) 769-5210

Beth Breeding

Associate Director, PR & Communications, Livestock, Equine & Ag

Boehringer Ingelheim Animal Health

(703) 946-0370

Share

Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

When do you vaccinate your horse?
275 votes · 275 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!